Treatment Options for Sacroiliac Joint Disorders

Treatments can vary depending on the severity of your symptoms and how much they limit your everyday activities. Below are some of the treatment options you may want to discuss with your doctor, depending on your symptoms. Nonsurgical Treatment for Sacroiliac Joint Disorders As a first line of treatment, your doctor may prescribe any one…

Technological Advancements in Pain Control & Minimally-Invasive Surgery

YOU’RE INVITED Wednesday December 4, 2013 // 6:00 pm // Ocean Prime – Troy The Michigan Surgical Hospital and Lakes Surgery Center present Technological Advancements in Pain Control & Minimally-Invasive Surgery Dinner Presentation Agenda: 6:30 pm: Introduction 6:40 pm: Dr. Baisa presents “An Innovative & Personalized Approach to Pain Management”. 7:40 pm: Dr. Ron Lederman…

Clinical guidelines for diagnosis and treatment of lumbar disc herniation

Clinical guidelines for diagnosis and treatment of lumbar disc herniation with radiculopathy by NASS Major Recommendations What history and physical examination findings are consistent with the diagnosis of lumbar disc herniation with radiculopathy? Manual muscle testing, sensory testing, supine straight leg raise, Lasegue’s sign and crossed Lasegue’s sign are recommended for use in diagnosing lumbar…

Two-Level Disc Replacement Reduces Reoperation vs Fusion

Patients with 2-level symptomatic cervical disc degeneration fare better in terms of future secondary surgeries when their discs are replaced rather than fused, a new study shows. “We found out that the results are really better,” first author Robert Jackson, MD, from Orange County Neurosurgical Associates in Laguna Hills, California, told Medscape Medical News. Dr….

No Benefit From Dose-Dense Chemo in Glioblastoma

Intensified chemoradiation with temozolomide for newly diagnosed glioblastoma failed to improve survival or slow disease progression, according to results of a randomized trial. Patients randomized to conventional treatment with radiation therapy and temozolomide (Temodar) had a median overall survival (OS) of 16.6 months, whereas patients who received radiation and dose-dense temozolomide had a median survival…

Severe depression may be treated with deep Brain stimulation DBS

Assessment of deep brain stimulation for patients with treatment-resistant depression has inched forward over the past decade with promising results but remains in its early days with a total worldwide experience of roughly 60 patients. That total includes patients who have received deep brain stimulation (DBS) leads placed in six different brain regions. However, the…

Time is Essential to Spare Brain After Ischemic Stroke: Less than 3 Hours Window

The Massachusetts General Hospital acute stroke imaging algorithm: an experience and evidence based approach. The Massachusetts General Hospital Neuroradiology Division employed an experience and evidence based approach to develop a neuroimaging algorithm to best select patients with severe ischemic strokes caused by anterior circulation occlusions (ACOs) for intravenous tissue plasminogen activator and endovascular treatment.

Peanut Butter and Alzheimer?

“Could a scoop of peanut butter and a ruler become that elusive test?” If you treat the elderly, or any member of the growing number of families devastated by Alzheimer’s disease, you may be asked some version of that question, as posed by CBS News, in the coming weeks. You can thank media coverage of…

FDA tightens Opiod Labeling to stress the dangers of its long term use!

The FDA has ordered a class-wide label change for long-acting opioids such as OxyContin (oxycodone) aimed at limiting use of these drugs to patients with severe, refractory pain. The move, announced at press briefing Tuesday, is part of a handful of changes that the agency hopes will curb an ongoing prescription painkiller epidemic, including a…

Michigan Brain is Pleased to Offer Artificial Disc Replacement

AUSTIN, TX (August 28,  2013) – LDR, a privately held medical device company offering exclusive spinal implant technologies for both non-fusion and fusion applications, today announced that it has received a letter of approval from the U.S. Food and Drug Administration (FDA) allowing the commercial sale and distribution of the Mobi-C Cervical Disc (Mobi-C) for…